Jump to section
To organize the world’s digital health products by performance, through clinically crowdsourced data generation.
Digital health has been on the rise in recent years, a broad concept that includes solutions for telemedicine, teleconsultation and health apps. While acceptance of these services has grown amongst all stakeholders, the companies building these solutions can often struggle to access the expertise needed to deliver these solutions.
MDisrupt is helping to catalyse this shift by aiding digital health companies with the healthcare hurdles they face. Primarily that has involved helping to supply health experts across a range of disciplines to populate these products.
Now, the company is expanding its services and introducing guidance for achieving regulatory approval as well as developing an integrated technology platform that organizes the world’s digital health products by performance to help with data-driven health decisions.
Perhaps the startups biggest challenge will be creating such a range of products, each with their own impact. However, it is clear that MDisrupt has landed on a fundamental truth in the space: a new swarm of digital health companies need help navigating the healthcare industry. MDisrupt fairly believes it can be part of the answer.
Steph
Company Specialist at Welcome to the Jungle
Nov 2024
$1m
EARLY VC
Oct 2023
$3m
SEED
Ruby Gadelrab
(CEO)Served on the executive team at 23andMe as VP of Commercial Marketing and has worked for many leading companies in the biotech and genetic spaces.